SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aspira Women's Health Inc. (AWH) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+3924.4%).
- Analyst consensus target $3.30 (+3924.4% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 46/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AWH
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.30
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.37
Book Value / Share$0.00
Revenue / Share$0.27
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$3.30 (+3924.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-4.30 |
$2.64M |
$-14.97M |
-566.5% |
| 2017 |
$-2.77 |
$3.12M |
$-10.5M |
-336.3% |
| 2018 |
$-2.43 |
$3.05M |
$-11.37M |
-372.5% |
| 2019 |
$-2.57 |
$4.54M |
$-14.85M |
-327.1% |
| 2020 |
$-2.63 |
$4.65M |
$-17.63M |
-379.1% |
| 2021 |
$-4.28 |
$6.81M |
$-31.71M |
-465.5% |
| 2022 |
$-41.66 |
$8.18M |
$-21.58M |
-263.6% |
| 2023 |
$-1.81 |
$9.15M |
$-16.69M |
-182.3% |
| 2024 |
$-0.93 |
$9.18M |
$-13.09M |
-142.6% |
| 2025 |
$-0.37 |
$9.22M |
$-12.78M |
-138.7% |
